Precision Drilling
PDS
Lantheus
LNTH
eBay
EBAY
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
(Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -29.67%18.31M | -24.83%21.2M | 241.96%22.21M | 241.96%22.21M | 119.02%23.73M | 49.01%26.04M | 14.23%28.21M | -78.00%6.49M | -78.00%6.49M | -69.90%10.83M |
-Cash and cash equivalents | -30.09%18.06M | -25.20%20.96M | 248.62%21.95M | 248.62%21.95M | 120.85%23.46M | 49.24%25.84M | 14.35%28.02M | -78.53%6.3M | -78.53%6.3M | -70.32%10.62M |
-Short-term investments | 25.14%247.8K | 31.42%247.1K | 30.41%258.7K | 30.41%258.7K | 26.56%265.91K | 24.01%198.01K | -0.41%188.03K | 3.11%198.38K | 3.11%198.38K | 3.05%210.11K |
Receivables | -86.86%44.17K | -92.41%30.32K | -87.83%51.34K | -87.83%51.34K | -7.15%334.97K | 58.23%336.16K | 29.18%399.66K | -86.79%421.86K | -86.79%421.86K | 37.38%360.77K |
-Accounts receivable | -86.86%44.17K | -92.41%30.32K | -87.83%51.34K | -87.83%51.34K | -7.15%334.97K | 58.23%336.16K | 29.18%399.66K | -86.79%421.86K | -86.79%421.86K | 37.38%360.77K |
Prepaid assets | -34.47%318.21K | -27.09%468.12K | -46.34%338.82K | -46.34%338.82K | -46.10%444.71K | -43.11%485.58K | 19.48%642.04K | 31.74%631.4K | 31.74%631.4K | 1.04%825.13K |
Total current assets | -30.48%18.67M | -25.80%21.7M | 199.41%22.6M | 199.41%22.6M | 103.90%24.51M | 44.87%26.86M | 14.53%29.25M | -77.26%7.55M | -77.26%7.55M | -67.58%12.02M |
Non current assets | ||||||||||
Net PPE | 7.84%115.81M | 9.15%116.1M | 4.10%115.01M | 4.10%115.01M | 5.83%108.08M | 10.26%107.39M | 15.62%106.37M | 27.33%110.48M | 27.33%110.48M | 20.81%102.13M |
-Gross PPE | 7.97%116.69M | 9.29%116.94M | 4.14%115.8M | 4.14%115.8M | 5.76%108.81M | 10.17%108.08M | 15.48%107M | 27.26%111.19M | 27.26%111.19M | 20.86%102.89M |
-Accumulated depreciation | -28.27%-880.87K | -33.87%-841.9K | -10.34%-789.61K | -10.34%-789.61K | 3.68%-732.09K | 3.20%-686.75K | 4.06%-628.88K | -16.42%-715.6K | -16.42%-715.6K | -28.12%-760.08K |
Investments and advances | -84.35%43.54K | -80.75%54.6K | -80.03%56.54K | -80.03%56.54K | 12.72%325.31K | -7.38%278.13K | -6.51%283.65K | -43.01%283.08K | -43.01%283.08K | -48.31%288.59K |
Non current accounts receivable | ---- | ---- | ---- | ---- | 5.10%5.65M | 15.25%5.63M | 32.40%5.58M | ---- | ---- | 74.70%5.37M |
Total non current assets | 2.25%115.85M | 3.49%116.16M | 3.89%115.07M | 3.89%115.07M | 5.81%114.05M | 10.45%113.3M | 16.28%112.24M | 21.86%110.76M | 21.86%110.76M | 22.25%107.79M |
Total assets | -4.02%134.52M | -2.57%137.86M | 16.36%137.67M | 16.36%137.67M | 15.65%138.56M | 15.72%140.16M | 15.92%141.49M | -4.65%118.31M | -4.65%118.31M | -4.34%119.81M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -67.87%371.65K | -65.85%747.93K | -56.79%625.57K | -56.79%625.57K | -75.91%841.5K | -71.98%1.16M | -55.54%2.19M | -41.26%1.45M | -41.26%1.45M | 48.41%3.49M |
-accounts payable | -67.64%333.83K | -66.21%667.65K | -58.66%575.27K | -58.66%575.27K | -76.37%810.75K | -74.44%1.03M | -59.32%1.98M | -33.34%1.39M | -33.34%1.39M | 48.92%3.43M |
-Due to related parties current | -69.80%37.83K | -62.44%80.27K | -10.34%50.3K | -10.34%50.3K | -50.17%30.75K | 36.74%125.23K | 217.59%213.71K | -85.12%56.1K | -85.12%56.1K | 24.96%61.71K |
Current accrued expenses | --667.45K | --590.84K | -33.80%588.57K | -33.80%588.57K | ---- | ---- | ---- | -36.71%889.03K | -36.71%889.03K | ---- |
Current liabilities | -10.18%1.04M | -38.86%1.34M | -48.04%1.21M | -48.04%1.21M | -75.91%841.5K | -71.98%1.16M | -55.54%2.19M | -39.61%2.34M | -39.61%2.34M | 48.41%3.49M |
Non current liabilities | ||||||||||
Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total liabilities | -10.18%1.04M | -38.86%1.34M | -48.04%1.21M | -48.04%1.21M | -75.91%841.5K | -71.98%1.16M | -55.54%2.19M | -39.61%2.34M | -39.61%2.34M | 48.41%3.49M |
Shareholders'equity | ||||||||||
Share capital | 0.84%182.76M | 0.85%182.37M | 16.79%182.01M | 16.79%182.01M | 17.25%181.88M | 17.19%181.23M | 17.44%180.82M | 1.39%155.84M | 1.39%155.84M | 1.51%155.12M |
-common stock | 0.84%182.76M | 0.85%182.37M | 16.79%182.01M | 16.79%182.01M | 17.25%181.88M | 17.19%181.23M | 17.44%180.82M | 1.39%155.84M | 1.39%155.84M | 1.51%155.12M |
Retained earnings | -6.61%-76.65M | -7.86%-75.9M | -8.78%-74.65M | -8.78%-74.65M | -9.59%-73.16M | -11.49%-71.89M | -12.39%-70.37M | -13.37%-68.62M | -13.37%-68.62M | -14.73%-66.76M |
Gains losses not affecting retained earnings | -35.79%6.93M | 0.23%9.96M | -8.96%9.31M | -8.96%9.31M | -1.04%9.85M | 8.95%10.79M | 4.63%9.94M | -12.62%10.23M | -12.62%10.23M | -24.11%9.95M |
Other equity interest | 7.45%20.44M | 6.25%20.25M | 6.95%19.93M | 6.95%19.93M | 6.76%19.31M | 11.82%19.02M | 16.32%19.06M | 21.05%18.64M | 21.05%18.64M | 19.19%18.09M |
Total stockholders'equity | -4.07%133.48M | -1.99%136.67M | 17.68%136.61M | 17.68%136.61M | 18.44%137.87M | 18.85%139.15M | 18.95%139.45M | -3.49%116.08M | -3.49%116.08M | -5.30%116.4M |
Noncontrolling interests | --0 | -1.40%-153.93K | -41.97%-156.37K | -41.97%-156.37K | -78.53%-155.12K | -73.04%-151.55K | -53.00%-151.8K | -54.69%-110.14K | -54.69%-110.14K | -263.84%-86.89K |
Total equity | -3.97%133.48M | -1.99%136.52M | 17.66%136.45M | 17.66%136.45M | 18.40%137.72M | 18.81%139M | 18.92%139.3M | -3.53%115.97M | -3.53%115.97M | -5.35%116.32M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |